Stockreport

RBC Capital Maintains a Sector Perform Rating on Beam Therapeutics (BEAM), Here's Why [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF Beam Therapeutics Inc. (NASDAQ: BEAM ) is one of the top gene therapy stocks to buy according to hedge funds . On February 25, RBC Capital adjusted the price target on [Read more]